#disease

June 5, 2025
PRNewswire
Artificial Intelligence

Stand Up To Cancer and SandboxAQ Launch Collaboration to Advance Treatment Innovation

Stand Up To Cancer® (SU2C) and SandboxAQ today announced a collaboration that brings SandboxAQ’s Large Quantitative Models (LQMs) to SU2C-funded cancer research projects. The initiative aims to accelerate the development of new treatments. SU2C...

May 29, 2025
PRNewswire
Biotechnology

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson’s Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Ltd. (NYSE: BHVN) (“Biohaven”), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies to treat a broad range of rare and common diseases,...